InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quali... ( RESEARCH TRIANGLE PARK N.C. March...)

InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quality Affairs

Date:3/6/2008

RESEARCH TRIANGLE PARK, N.C., March 6 /PRNewswire/ -- InnerPulse, Inc., a privately held company with a disruptive technology for the treatment of abnormal heart rhythms, announced the appointment of Elsa Abruzzo to the newly formed position of Vice-President of Regulatory and Quality Affairs. Ms. Abruzzo has more than 18 years of experience in the medical device industry including cardiac devices, such as heart valves, neurovascular embolic devices, and biomaterials.

Ms. Abruzzo, 40, most recently served as Vice-President Regulatory and Clinical Affairs with AtriCure, Inc., a manufacturer of cardiac ablation devices. Prior to that Elsa was with Percutaneous Valve Technologies, Inc. (PVT) where she served as head of regulatory and clinical affairs for a breakthrough percutaneous aortic valve technology. Prior to PVT, Elsa spent 10 years with CryoLife, Inc. (biomaterials, tissue heart valves and vascular grafts) and Cordis Johnson and Johnson (vascular devices), all in regulatory and quality affairs.

"We are delighted to have someone with Elsa's extensive experience join our executive team at this important juncture of the Company's evolution. She will have a key leadership role as we initiate our clinical studies and move closer to gaining regulatory approval of our novel defibrillator technology. Her experience in leading several technologies successfully through the regulatory approval process over the past 18 years will provide great value as the Company begins our clinical trials," said InnerPulse President and Chief Executive Officer Daniel A. Pelak.

Elsa is a graduate of the University of Miami with a degree in Industrial and Manufacturing Engineering.

About InnerPulse, Inc.

Founded in 2003, InnerPulse is a privately held, early-stage company pioneering a novel technology for those patients who have cardiac rhythm disorders. More information is available at http://www.
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. Ventas Appoints James D. Shelton and Robert D. Reed to Board
2. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
3. China Sky One Medical, Inc. Appoints Four Independent Board Members
4. Stiefel Laboratories, Inc. Appoints New President
5. Asthma Foundation Appoints Award-Winning Scholar to Top Policy Position
6. New Jersey Hospital Association Names New Chairman, Appoints Board Officers and New Members
7. Belden Appoints Mary S. McLeod of Pfizer Inc. to Board of Directors
8. HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
9. CryoCath Appoints New Chief Financial Officer
10. Ceremed Appoints Vice President for Sales and Business Development
11. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board

Post Your Comments:

InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quali...( RESEARCH TRIANGLE PARK N.C. March...),Health